The survey is to provide technical information necessary for the development of Community veterinary legislation as appropriate. Given the importance of collecting comparable data on the prevalence of MRSA in breeding pigs in the Member States, the Member States should be granted a Community financial contribution for implementing the specific requirements of the survey. It is appropriate to reimburse 100 % of the costs incurred on the purchase of swabs and the laboratory testing, subject to a ceiling. All other costs incurred, such as costs for sampling, travelling and administration, should not be eligible for any Community financial contribution.
Recital 11, Decision_act (EU) 2008/55
In forcesince 20 Dec 2007